Ambience Healthcare is an ambient AI platform for documentation, coding, and clinical documentation integrity (CDI) designed to reduce administrative burden and protect revenue integrity at the point of care. Its platform provides real-time, coding-aware documentation and is live across outpatient, emergency, and inpatient settings, supporting more than 100 specialties. The system integrates directly with major EHRs including Epic, Oracle Cerner, and athenahealth. Ambience is used by U.S. health systems including Cleveland Clinic, UCSF Health, Houston Methodist, and Memorial Hermann. The company will use the Series C proceeds to expand its AI platform across more healthcare organizations, accelerate product development, and support broader deployment across ambulatory, emergency, and inpatient care settings. Ambience is headquartered in San Francisco and was founded in 2020. Ambience Healthcare offers an "operating system" that helps clinicians complete large volumes of administrative, operational and revenue-cycle work across dozens of ambulatory specialties such as cardiology, oncology, pediatrics and ENT. Its product suite includes AutoScribe (note generation), AutoCDI (coding and audit trails), AutoRefer (handoffs), AutoAVS (after-visit summaries) and a soon-to-launch AutoPrep to prepare clinicians for appointments. The company says it is focused on the U.S. market and lists customers including UCSF, Memorial Hermann Health System, John Muir Health, The Oncology Institute, GI Alliance, Midi Health and Eventus WholeHealth. Ambience does not disclose total customer count or platform data usage, nor the specific language models it uses, though the OpenAI investment signals a possible platform partnership. The product currently does not aim to provide diagnoses, but the company has the capability to add diagnostic features to its roadmap. Financially, Ambience has raised $70 million in its latest round and has now raised $100 million in total; it is not disclosing a valuation.

Total raised

$313M

Funding rounds

2

Latest round

Series C

Latest activity

Aug 2025